Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: Inhibition by resveratrol

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 1, 2006, Pages

  Conover, Cheryl A ^a,c   Bale, Laurie K ^a   Harrington, Sean C ^a   Resch, Zachary T ^a   Overgaard, Michael T ^b   Oxvig, Claus ^b  

^a Endocrine Research Unit   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c MAYO CLINIC   (United States)

Author keywords

Insulin like growth factor I; Interleukin 1 ; Tumor necrosis factor

Indexed keywords

DACTINOMYCIN; INTERLEUKIN 1BETA; MESSENGER RNA; PREGNANCY ASSOCIATED PLASMA PROTEIN A; RESVERATROL; SOMATOMEDIN BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ARTICLE; BLOOD VESSEL INJURY; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SMOOTH MUSCLE FIBER; CORONARY BLOOD VESSEL; CYTOLOGY; DRUG EFFECT; GENETICS; GRAPE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE; WINE;

VITACEAE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CORONARY VESSELS; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INTERLEUKIN-1; MUSCLE, SMOOTH, VASCULAR; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; VITIS; WINE;

EID: 33644821240     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00199.2005     Document Type: Article

References (45)

1. Anwar A, Zahid AA, Scheidegger KJ, Brink M, and Delafontaine P. Tumor necrosis factor-α regulates insulin-like growth factor-1 and insulinlike growth factor binding protein-3 expression in vascular smooth muscle. Circulation 105: 1220-1225, 2002.
2. Araim O, Ballantyne J, Waterhouse AL, and Sumpio BE. Inhibition of vascular smooth muscle cell proliferation with red wine and red wine polyphenols. J Vasc Surg 35: 1226-1232, 2002.
3. Aso Y, Okumura KI, Wakabayashi S, Takebayashi K, Taki S, and Inukai T. Elevated pregnancy-associated plasma protein-A in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. J Clin Endocrinol Metab 89: 5713-5717, 2004.
4. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, Virmani R, Oxvig C, and Schwartz RS. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345: 1022-1029, 2001.
5. Bayes-Genis A, Conover CA, and Schwartz RS. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86: 125-130, 2000.
6. Bayes-Genis A, Schwartz RS, Lewis DA, Overgaard MT, Christiansen M, Oxvig C, Ashai K, Holmes DR Jr, and Conover CA. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 21: 335-341, 2001.
7. Boldt HB, Overgaard MT, Laursen LS, Weyer K, Sottrup-Jensen L, and Oxvig C. Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem J 358: 359-367, 2001.
8. Bradamante S, Barenghi L, and Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Cru Rev 22: 169-188, 2004.
9. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle P, and Neumeier D. Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion. J Clin Invest 97: 1715-1722, 1996.
10. Byun D, Mohan S, Yoo M, Sexton C, Baylink DJ, and Qin X. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J Clin Endocrinol Metab 86: 847-854, 2001.
11. Cercek B, Yamashita M, Dimayuga P, Zhu J, Fishbein MC, Kaul S, Shah PK, Nilsson J, and Regnstrom J. Nuclear factor-κB activity and arterial response to balloon injury. Atherosclerosis 131: 59-66, 1997.
12. Chen BK, Overgaard MT, Bale LK, Resch ZT, Christiansen M, Oxvig C, and Conover CA. Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: identification of a novel inducible inhibitor. Endocrinology 143: 1199-1205, 2002.
13. Conover CA, Durham SK, Zapf J, Masiarz FR, and Kiefer MC. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF binding protein-4 mutants. J Biol Chem 270: 4395-4400, 1995.
14. Delafontaine P, Song YH, and Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 24: 435-444, 2004.
15. Dollery CM, McEwan JR, and Henny AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 77: 863-868, 1995.
16. Duan C and Clemmons DR. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells. J Biol Chem 273: 16883-16842, 1998.
17. Galis ZS, Sukhova GK, Lark MW, and Libby P. Increased expression of matrix metalloproteinase and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 12: 1075-1095, 1998.
18. Gustafsson T, Andersson P, and Arnqvist HJ. Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells. J Endocrinol 161: 245-253, 1999.
19. Hayford K, Boes M, Dake BL, and Bar RS. Regulation of IGF binding proteins in human aorta vascular smooth muscle cells by cAMP dexamethasone and IGF-I. Growth Horm IGF Res 8: 369-375, 1998.
20. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML, and Zeiher AM: CAPTURE Study Investigators. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 45: 229-237, 2005.
21. Holmes-McNary M and Baldwin AS Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the I B kinase. Cancer Res 60: 3477-3483, 2000.
22. Iijima K, Yoshizumi M, Hashimoto M, Kim S, Eto M, Ako J, Liang YQ, Sudoh N, Hosoda K, Nakahara K, Toba K, and Ouchi Y. Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene. Circulation 101: 805-811, 2000.
23. Jiang B, Xu S, Brecher P, and Cohen RA. Growth factors enhance interleukin-1β-induced persistant activation of nuclear factor-κB in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 22: 1811-1816, 2002.
24. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, and Nilsson J. Tumor necrosis factor-α activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 17: 490-497, 1997.
25. Laursen LS, Overgaard MT, Nielsen CG, Boldt HB, Hopmann KH, Conover CA, Sottrup-Jensen L, Giudice LC, and Oxvig C. Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem J 367: 31-40, 2002.
26. Laursen LS, Overgaard MT, Weyer K, Boldt HB, Ebbesen P, Christiansen M, Sottrup-Jensen L, Giudice LC, and Oxvig C. Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J Biol Chem 277: 47225-47234, 2002.
27. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR III, and Conover CA. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96: 3149-3153, 1999.
28. Li N and Karin M. Is NF-κB the sensor of oxidative stress? FASEB J 13: 1137-1143, 1999.
29. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT, Stetler-Stevenson WG, Froehlich J, and Lakatta EG. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 148: 121-128, 1996.
30. -ΔΔCT method. Methods 25: 402-408, 2001.
31. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PRF, and Thompson MM. Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute plaque disruption. Stroke 31: 40-47, 2000.
32. Lund J, Qin QP, Ilva T, Pettersson K, Voipio-Pulkki LM, Porela P, and Pulkki K. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 108: 1924-1926, 2003.
33. WAF1/CIP1 pathway. Biochem Biophys Res Commun 311: 546-552, 2003.
34. Ortiz CO, Chen BK, Bale LK, Overgaard MT, Oxvig C, and Conover CA. Transforming growth factor-β regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J Bone Miner Res 18: 1066-1072, 2003.
35. Qin X, Byun D, Lau KHW, Baylink DJ, and Mohan S. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch Biochem Biophys 379: 209-216, 2000.
36. Rajavashisth TB, Xu XP, Jovinge S, Meisel S, Xu XO, Chai NN, Fishbein MC, Kaul S, Cercek B, Sharifi B, and Shah PK. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques. Evidence for activation by proinflammatory mediators. Circulation 99: 3103-3109, 1999.
37. Resch ZT, Chen BK, Bale LK, Oxvig C, Overgaard MT, and Conover CA. Pregnancy-associated plasma protein A gene expression as a target of inflammatory cytokines. Endocrinology 145: 1124-1129, 2004.
38. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999.
39. Sato M, Maulik N, and Das DK. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann NY Acad Sci 957: 122-135, 2002.
40. Selzman CH, Shames BD, Reznikov LL, Miller SA, Meng X, Barton HA, Werman A, Harken AH, Dinarello CA, and Banerjee A. Liposomal delivery of purified inhibitory-κBα inhibits tumor necrosis factor-α-induced human vascular smooth muscle proliferation. Circ Res 84: 867-875, 1999.
41. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, and Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99: 2503-2509, 1999.
42. Sun AY, Simonyi A, and Sun GY. The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 32: 314-318, 2002.
43. Tsai SH, Lin-Shiau SY, and Lin JK. Suppression of nitric oxide synthase and the downregulation of the activation of NFκB in macrophages by resveratrol. Br J Pharmacol 126: 673-680, 1999.
44. Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou JG, and Huang YZ. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 8: 3-17, 2001.
45. Yateman ME, Claffey DC, Cwyfan Hughes SC, Frost VJ, Wass JAH, and Holly JMP. Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production. J Endocrinol 137: 151-159, 1993.